This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Axenfeld–Rieger syndrome | |
|---|---|
| Name | Axenfeld–Rieger syndrome |
| Field | Ophthalmology |
| Symptoms | Peripheral anterior segment dysgenesis, iris anomalies, dental hypodontia |
| Onset | Congenital |
| Duration | Lifelong |
| Causes | Mutations in PITX2, FOXC1 |
| Differential | Iridogoniodysgenesis, Peters anomaly, Aniridia |
| Treatment | Medical, surgical, genetic counseling |
Axenfeld–Rieger syndrome is a congenital anterior segment dysgenesis affecting the eye with systemic anomalies, characterized by structural abnormalities of the iris, cornea, and trabecular meshwork and frequently associated with dental and umbilical malformations. First described in historical ophthalmology literature during the 19th and 20th centuries, the condition has been clarified by genetic studies linking transcription factor mutations to craniofacial and ocular development. Contemporary management involves multidisciplinary collaboration among specialists in ophthalmology, dentistry, genetics, and pediatrics.
Patients present with anterior segment anomalies including posterior embryotoxon, corectopia, polycoria, and peripheral iridocorneal adhesions that disrupt aqueous outflow and predispose to glaucoma; these ocular features are often documented in clinical series from referral centers such as Moorfields Eye Hospital, Bascom Palmer Eye Institute, Wills Eye Hospital, Johns Hopkins Hospital, and Massachusetts Eye and Ear. Systemic manifestations include hypodontia, microdontia, and delayed tooth eruption frequently managed by teams at institutions like American Dental Association-affiliated clinics, as well as maxillofacial anomalies seen by surgeons at Mayo Clinic, Cleveland Clinic, and Great Ormond Street Hospital; umbilical defects, redundant periumbilical skin, and abdominal wall variations are reported in pediatric cohorts at Boston Children's Hospital and Great Ormond Street Hospital. Additional craniofacial, cardiovascular, and skeletal findings—such as craniosynostosis, congenital heart defects evaluated at Children's Hospital of Philadelphia, and limb anomalies seen in case series from St. Jude Children's Research Hospital—are described in multidisciplinary case reports that inform surveillance protocols used at tertiary centers like Royal Brompton Hospital and GOSH. Visual impairment from secondary glaucoma contributes to referrals to pediatric ophthalmology units at Seattle Children's Hospital and neuro-ophthalmology services at National Institutes of Health.
Pathogenic variants in transcription factor genes including PITX2 and FOXC1, identified through linkage studies and next-generation sequencing performed at research centers such as Broad Institute, Wellcome Sanger Institute, Columbia University Medical Center, University of Cambridge, and Harvard Medical School, underlie the anterior segment malformations and systemic phenotypes. Molecular mechanisms implicate disrupted neural crest cell migration and dysregulated regulation of downstream targets involved in ocular anterior segment and craniofacial morphogenesis; these pathways are studied in model systems at laboratories in Max Planck Society, University of California, San Francisco, Stanford University School of Medicine, and European Molecular Biology Laboratory. Genotype–phenotype correlations show allelic heterogeneity and variable expressivity, with copy number variations and regulatory region mutations reported in genomic analyses from Cold Spring Harbor Laboratory and consortium studies coordinated by the European Society of Human Genetics and the American College of Medical Genetics and Genomics.
Diagnosis is clinical, based on slit-lamp examination, gonioscopy, and documentation of anterior segment anomalies corroborated by imaging modalities such as anterior segment optical coherence tomography and ultrasound biomicroscopy available at tertiary eye centers including Wills Eye Hospital and Bascom Palmer Eye Institute. Genetic testing for PITX2, FOXC1, and other implicated loci is performed by diagnostic laboratories affiliated with Mayo Clinic Laboratories, LabCorp, Quest Diagnostics, and academic molecular genetics units at Johns Hopkins University and University College London to confirm pathogenic variants and inform family counseling handled by genetics services at Great Ormond Street Hospital and Children's Hospital of Philadelphia. Differential diagnosis includes conditions such as aniridia evaluated in clinics at National Eye Institute and Peters anomaly encountered in pediatric services at Great Ormond Street Hospital.
Ocular management centers on glaucoma surveillance and control using topical antiglaucoma medications, laser trabeculoplasty, and filtration surgeries including trabeculectomy and glaucoma drainage devices with perioperative care performed at subspecialty centers like Bascom Palmer Eye Institute and Wills Eye Hospital. Corneal and iris anomalies may require surgical interventions by anterior segment surgeons at Moorfields Eye Hospital, while amblyopia therapy and visual rehabilitation are coordinated with pediatric services at Boston Children's Hospital and low-vision programs at Royal National Institute of Blind People. Dental anomalies are managed by pediatric dentists and orthodontists in tertiary clinics such as American Academy of Pediatric Dentistry-affiliated centers and maxillofacial teams at Mayo Clinic; systemic anomalies require input from cardiology, endocrinology, and genetics clinics at institutions like Cleveland Clinic and Johns Hopkins Hospital. Genetic counseling, family cascade testing, and reproductive options are provided through services at National Society of Genetic Counselors-affiliated centers.
Reported prevalence estimates derive from case series and registry data collected by academic hospitals and population studies coordinated by organizations such as the European Rare Disease Research Coordination and national registries in United Kingdom, United States, and Australia; the syndrome is considered rare, with estimates varying by ascertainment method and the inclusion of related anterior segment dysgenesis phenotypes. Familial clustering with autosomal dominant inheritance and variable penetrance has been documented in pedigrees studied at University of Oxford, University of Toronto, University of Sydney, and Karolinska Institutet.
Long-term prognosis depends on severity of glaucoma, timely intervention, and multispecialty management provided by referral centers such as Bascom Palmer Eye Institute, Moorfields Eye Hospital, and Johns Hopkins Hospital; uncontrolled intraocular pressure can lead to irreversible optic nerve damage and visual loss prompting low-vision support from organizations like Royal National Institute of Blind People and American Foundation for the Blind. Systemic complications including dental issues and congenital cardiac anomalies influence overall morbidity and require coordinated lifelong care overseen by multidisciplinary teams at Great Ormond Street Hospital, Boston Children's Hospital, and adult transition services at Guy's and St Thomas' NHS Foundation Trust.
Category:Rare genetic syndromes